Public Release: 

Single-administration polio vaccine

Proceedings of the National Academy of Sciences

Researchers developed a single-administration vaccine strategy for polio using an injectable microsphere bearing inactivated polio vaccine (IPV) that releases stable antigen over time; the researchers used biocompatible excipients to stabilize IPV, and found that injecting the microspheres into rats elicited a strong immune response against all three IPV antigens.


Article #17-20970: "Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response," by Stephany Y. Tzeng et al.

MEDIA CONTACT: Robert Langer, Massachusetts Institute of Technology, Cambridge, MA; tel: 617-253-3107; e-mail: <>

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.